NSF taken to task

Budget hearing raises still unresolved management and funding disparities

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON, DC—The National Science Foundation (NSF) has failed to address fully half of the recommendations outlined last year by its own Inspector General to improve management and oversight of large infrastructure projects.

NSF Inspector General (IG) Christine Boesz told a Senate appropriations subcommittee Thursday that key recommendations "on developing new project and financial management policies and procedures remain unresolved by NSF management." With increased funding for large facilities and infrastructure projects underway "this issue needs to become one of greater urgency," she testified. "We are disappointed that the whole process could not have been accelerated."

Legislators have for several years questioned whether NSF's bureaucracy would hinder its ability to manage high-quality research, especially given a huge infusion of funds for "tools"—instrumentation and equipment, facilities, accelerators, telescopes and the like. NSF is seeking more than $1.34 billion in this area for FY 2004, nearly 25 percent of the agency's total budget.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development